150 related articles for article (PubMed ID: 36145360)
1. Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy.
Yin Y; Li S; Liang X; Li K; Xie M; Hu B
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145360
[TBL] [Abstract][Full Text] [Related]
2. Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer.
Sun X; Wang X; Feng W; Guo H; Tang C; Lu Y; Xiang X; Bao Y
Oncol Lett; 2017 Apr; 13(4):2089-2096. PubMed ID: 28454366
[TBL] [Abstract][Full Text] [Related]
3. A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling.
Lin Q; Luo L; Wang H
Front Oncol; 2021; 11():644956. PubMed ID: 34026619
[TBL] [Abstract][Full Text] [Related]
4. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
5. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
Cherradi S; Garambois V; Marines J; Andrade AF; Fauvre A; Morand O; Fargal M; Mancouri F; Ayrolles-Torro A; Vezzo-Vié N; Jarlier M; Loussaint G; Huvelle S; Joubert N; Mazard T; Gongora C; Pourquier P; Boissière-Michot F; Rio MD
Cell Biosci; 2023 Apr; 13(1):72. PubMed ID: 37041570
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy.
Guo XW; Li SQ; Lei RE; Ding Z; Hu BL; Lin R
Front Oncol; 2022; 12():953321. PubMed ID: 36110947
[TBL] [Abstract][Full Text] [Related]
8. Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients.
Geevimaan K; Guo JY; Shen CN; Jiang JK; Fann CSJ; Hwang MJ; Shui JW; Lin HT; Wang MJ; Shih HC; Li AF; Chang SC; Yang SH; Chen JY
Front Oncol; 2022; 12():883437. PubMed ID: 35719949
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy.
Zhou QN; Lei RE; Liang YX; Li SQ; Guo XW; Hu BL
Cancer Cell Int; 2023 May; 23(1):103. PubMed ID: 37245016
[TBL] [Abstract][Full Text] [Related]
10. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.
Jensen NF; Stenvang J; Beck MK; Hanáková B; Belling KC; Do KN; Viuff B; Nygård SB; Gupta R; Rasmussen MH; Tarpgaard LS; Hansen TP; Budinská E; Pfeiffer P; Bosman F; Tejpar S; Roth A; Delorenzi M; Andersen CL; Rømer MU; Brünner N; Moreira JM
Mol Oncol; 2015 Jun; 9(6):1169-85. PubMed ID: 25759163
[TBL] [Abstract][Full Text] [Related]
12. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
13. Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model.
Zhang Y; Xu M; Sun Y; Chen Y; Chi P; Xu Z; Lu X
Front Cell Dev Biol; 2020; 8():609832. PubMed ID: 33585448
[TBL] [Abstract][Full Text] [Related]
14. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
15. DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients.
Lv MY; Wang W; Zhong ME; Cai D; Fan D; Li CH; Kou WB; Huang ZP; Duan X; Hu C; Zhu Q; He X; Gao F
Front Genet; 2022; 13():872238. PubMed ID: 35495147
[No Abstract] [Full Text] [Related]
16. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.
Poorebrahim M; Sadeghi S; Ghanbarian M; Kalhor H; Mehrtash A; Teimoori-Toolabi L
Cancer Chemother Pharmacol; 2020 Jan; 85(1):153-171. PubMed ID: 31781855
[TBL] [Abstract][Full Text] [Related]
18. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
19. Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer.
Abraham JP; Magee D; Cremolini C; Antoniotti C; Halbert DD; Xiu J; Stafford P; Berry DA; Oberley MJ; Shields AF; Marshall JL; Salem ME; Falcone A; Grothey A; Hall MJ; Venook AP; Lenz HJ; Helmstetter A; Korn WM; Spetzler DB
Clin Cancer Res; 2021 Feb; 27(4):1174-1183. PubMed ID: 33293373
[TBL] [Abstract][Full Text] [Related]
20. Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis.
Bu L; Huang F; Li M; Peng Y; Wang H; Zhang M; Peng L; Liu L; Zhao Q
PeerJ; 2021; 9():e11430. PubMed ID: 34035992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
